ESC 2020

2020 ESC Clinical Practice Guidelines

Hot Line Presentations

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By

Dr Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, EMPEROR-Reduced trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:40

First-in-class cardiac myosin inhibitor effective in obstructive hypertrophic cardiomyopathy

Presented By

Prof. Iacopo Olivotto, Azienda Ospedaliera Universitaria Careggi, Italy

Trial

Phase 3, EXPLORER-­HCM trial

Type

Peer-reviewed article

5 November 2020 13:37

Reduced cardiovascular outcomes with early rhythm control

Presented By

Prof. Paulus Kirchhof, University Heart & Vascular Center Hamburg, Germany

Trial

EAST-AFNET 4

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:35

Trimetazidine after successful PCI not associated with fewer cardiac events

Presented By

Prof. Roberto Ferrari, University of Ferrara, Italy

Trial

ATPCI trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:30

POPular TAVI: Aspirin-only antiplatelet strategy?

Presented By

Dr Jorn Brouwer, St Antonius Hospital, the Netherlands

Trial

POPular TAVI trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:28

Reduced NT-proBNP in HFpEF with sacubitril/valsartan

Presented By

Prof. Burkert Pieske, Charité University Medicine Berlin, Germany

Trial

Phase 3, PARALLAX study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:26

DAPA-CKD: Dapagliflozin improves CKD survival ± diabetes

Presented By

Prof. Hiddo Heerspink, University of Groningen, the Netherlands

Trial

DAPA-CKD trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:23

Low-dose colchicine reduces CV death and ischaemic events in coronary disease

Presented By

Dr Stefan Nidorf, Heart Care Western Australia, Australia

Trial

LoDoCo2 trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:19

Similar outcomes sPESI and HESTIA for pulmonary embolism triage

Presented By

Prof. Pierre-Marie Roy, University Hospital of Angers, France

Trial

HOME-PE trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:16

Antihypertensives also reduce CV risk in people with normal blood pressure

Presented By

Prof. Kazem Rahimi, University of Oxford, UK

Trial

BPLTTC study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:14

COVID-19: Continuing versus suspending ACE inhibitors and ARBs

Presented By

Prof. Renato Lopes, Duke University, USA

Trial

Phase 4, BRACE CORONA trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:10

Drug initiation strategy not associated with increased use of oral anticoagulants

Presented By

Prof. Sean Pokorney , Duke University, USA

Trial

IMPACT-AFib trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:07

Restrictive blood transfusion non-inferior and cost-effective strategy

Presented By

Prof. Philippe Gabriel Steg, University of Paris, Frane

Trial

REALITY trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:05

Late-Breaking Science

COVID and Cardiovascular Disease

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By

Prof. Yutao Guo , Chinese PLA General Hospital, China

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:27

The Yale COVID-19 Cardiovascular Registry

Presented By

Dr Manan Pareek, Yale University School of Medicine, USA

Trial

Yale COVID-19 Cardiovascular Registry

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:24

COVID-19 treatments and the importance of randomised trials

Presented By

Prof. Martin Landray, University of Oxford, UK

Trial

RECOVERY

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 11:49